Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "AiMeD"

507 News Found

PharmEasy launches AI-powered online physiotherapy service
Digitisation | May 06, 2026

PharmEasy launches AI-powered online physiotherapy service

The platform offers personalised recovery plans, AI-driven movement tracking, and access to certified physiotherapists for more than 250 conditions


Novartis locks in $23 billion US expansion with seventh new facility
News | May 05, 2026

Novartis locks in $23 billion US expansion with seventh new facility

The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics


Healthcare policymakers lay thrust on genetic screening and indigenous therapies for rare diseases
Public Health | May 05, 2026

Healthcare policymakers lay thrust on genetic screening and indigenous therapies for rare diseases

Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access


India and Japan deepen healthcare collaboration at 3rd joint committee meeting
Policy | May 05, 2026

India and Japan deepen healthcare collaboration at 3rd joint committee meeting

Discussions focused on digital health, non-communicable diseases, resilient supply chains, medical innovation, and healthcare workforce development


India unveils first-ever national framework to tackle childhood diabetes
Policy | May 04, 2026

India unveils first-ever national framework to tackle childhood diabetes

New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system


KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru
Healthcare | May 04, 2026

KIMS Hospitals launches Advanced Neurosciences Institute in Bengaluru

The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof


Bayer pushes stroke prevention drug forward in China as regulators accept key filing
News | May 02, 2026

Bayer pushes stroke prevention drug forward in China as regulators accept key filing

Stroke is the second-leading cause of death and the third-leading cause of disability worldwide


Indoco Remedies to exit ophthalmic business in strategic sale to Sunways India
News | May 02, 2026

Indoco Remedies to exit ophthalmic business in strategic sale to Sunways India

The transaction marks a clear portfolio reshuffle for Indoco


Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi
interviews | May 01, 2026

Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules


Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India
interviews | April 30, 2026

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems